Custom Antibody Market Overview:
The Custom Antibody Market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period. As such, an increase in research activity especially in the life sciences industry along with growing industry-academia collaborations are the primary growth drivers for this market. In addition, the objective behind custom antibody production is to acquire an antibody that performs well in a particular qualitative or quantitative immunodetection method. The quality of catalog antibodies (to ensure the reproducibility of results) is also an area of concern in this market, which is primarily why end users prefer custom-made antibodies.
Request For Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=164328301
Covid-19 Impact On The Global Custom Antibody Market
A mix of established pharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Vaccine-related research activities in pharmaceutical and biotechnology companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Due to the increase in research activities, both the availability of funding for research and the demand for antibodies, including custom antibodies, are expected to grow.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301
Market Segmentation:
By services, the antibody development segment accounted for the largest share of the custom antibody market in 2020.
Based on service, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. In 2020, the antibody development segment accounted for the largest share in the custom antibody market. The large share of this segment can be attributed to the increasing focus of researchers on high-quality custom antibodies for reproducibility, which can be hampered when using commercially available antibodies.
By type, the monoclonal antibody accounted for the largest share of the custom antibody market in 2020.
Based on type, the custom antibody market is segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The monoclonal antibodies segment accounted for the largest market share in 2020. This is because monoclonal antibodies provide high specificity and selectivity compared to other antibodies and are thus the preferred choice in all types of research studies.
By source, the mice accounted for the largest share of the custom antibody market in 2020.
Based on source, the custom antibody market has been segmented into mice, rabbits, and other sources. The mice segment accounted for the largest share of the custom antibody market in 2020. Mice are the most preferred hosts for research-use antibody production. Compared to other experimental animals, mice offer advantages of lower feeding costs and ease of maintenance & handling due to their small size.
Get Detailed Information:
https://www.marketsandmarkets.com/Market-Reports/custom-antibody-market-164328301.html
Key Players:
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US) are the prominent players operating in the custom antibody market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
0